Male breast cancer (MBC) accounts for approximately 1% of all breast cancers. Given the rarity of this disease, treatment of MBC generally follows the same principles as treatment of female breast cancer. However, the traditional surgical approach for MBC is modified radical mastectomy (MRM) or total simple mastectomy (TSM) instead of breast conservation surgery (BCS). The purpose of this study was to examine the feasibility of BCS as an alternative to mastectomy for MBC with respect to musculoskeletal functionality and treatment outcome.
Patients and Methods
A retrospective analysis was undertaken of all male patients with breast cancer who presented to Massachusetts General Hospital or Boston Medical Center for localized therapy from 1990 to 2003. Musculoskeletal functionality (tissue fibrosis, arm edema, and range of motion) and treatment outcome (local-regional control, disease-free survival, and overall survival) were evaluated. Functional/cosmetic outcomes were assessed by multidisciplinary review of patient follow-up visits and were scored as either “good-excellent” or “fair-poor” to account for subjectivity between different clinicians.
Forty-two patients in total were identified to undergo localized treatment. Thirty patients (71%) received MRM, 4 (10%) had TSM, and 8 (19%) underwent BCS. Actuarial overall 1-year fair-poor documented tissue fibrosis, arm edema, and decreased range of motion rates were 13%, 23%, and 27% for patients receiving MRM; 25%, 0%, and 50% for patients who underwent TSM; and 13%, 0%, and 0% for those undergoing BCS, respectively. Overall survival and disease-free survival were not statistically different between the groups.
These data suggest that breast conservation therapy may be considered a reasonable local treatment option for male patients presenting with breast cancer because it may offer functional advantages over mastectomy with comparable rates of local control and disease-free survival and overall survival.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Clinical Breast Cancer
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- Cancer statistics, 2008.CA Cancer J Clin. 2008; 58: 71-96
- Diagnosis and management of male breast cancer.World J Surg. 2008; 32: 2471-2476
- A 50-year experience of male breast cancer: is outcome changing?.Surg Oncol. 1993; 2: 325-333
- Male breast cancer: results of the treatments and prognostic factors in 397 cases.Eur J Cancer. 1995; 31A: 1960-1964
- Male breast cancer: a 22-year experience.Eur J Surg Oncol. 1998; 24: 548-552
- An analysis of male and female breast cancer treatment and survival among demographically identical pairs of patients.Surgery. 1999; 126 (discussion 780-1): 775-780
- Review article: epidemiology of male breast cancer. A meta-analysis of published case-control studies and discussion of selected aetiological factors.Int J Cancer. 1993; 53: 538-549
- Breast carcinoma in men: a population-based study.Cancer. 2004; 101: 51-57
- Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial.J Natl Cancer Inst. 2000; 92: 1143-1150
- Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer.N Engl J Med. 2002; 347: 1227-1232
- Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer.N Engl J Med. 2002; 347: 1233-1241
- Eighteen-year results in the treatment of early breast carcinoma with mastectomy vs. breast conservation therapy: the National Cancer Institute Randomized Trial.Cancer. 2003; 98: 697-702
- Changes in male breast cancer over a 30-year period.Am Surg. 2008; 74 (discussion 711-2): 707-711
- Current management of male breast cancer. A review of 104 cases.Ann Surg. 1992; 215 (discussion 457-9): 451-457
- Male breast carcinoma: a review of 229 patients who presented to the Princess Margaret Hospital during 40 years: 1955-1996.Cancer. 1999; 85: 629-639
- Male breast cancer: a review of the literature and a case report.Psychosomatics. 2002; 43: 326-330
- Psychological distress in men with breast cancer.J Clin Oncol. 2006; 24: 95-101
- Breast conservation for male breast carcinoma.Breast. 2007; 16: 653-656
- Breast conserving surgery with preservation of the nipple-areola complex as a feasible and safe approach in male breast cancer: a case report.J Med Case Reports. 2008; 2: 126
- Ductal carcinoma in situ (DCIS) of the male breast treated by lumpectomy and breast irradiation.Clin Oncol (R Coll Radiol). 1998; 10: 204-205
- Factors influencing cosmetic results after conservation therapy for breast cancer.Int J Radiat Oncol Biol Phys. 1995; 31: 753-764
Published online: July 29, 2013
Accepted: May 7, 2013
Received: February 21, 2013
© 2013 Elsevier Inc. Published by Elsevier Inc. All rights reserved.